HHV-6-positivity in diseases with demyelination

Journal of Clinical Virology

Volumn 61, Issue 2, 2014, Pages 216-219

  Pietiläinen Nicklén, Jenna ^a,b   Virtanen, Jussi O ^a   Uotila, Lasse ^c   Salonen, Oili ^c   Färkkilä, Markus ^b   Koskiniemi, Marjaleena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Demyelinating disease; Human herpesvirus 6; Isoelectric focusing; Multiple sclerosis; Oligoclonal bands

Indexed keywords

ALBUMIN; OLIGOCLONAL BAND; VIRUS ANTIBODY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ALBUMIN BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EVALUATION; CLINICAL FEATURE; DEMYELINATING DISEASE; DEMYELINATION; FEMALE; FOLLOW UP; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOASSAY; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY INFECTION; PRIORITY JOURNAL; RNA VIRUS INFECTION; BLOOD; CEREBROSPINAL FLUID; DEMYELINATING DISEASES; FINLAND; HEAD; IMMUNOLOGY; PATHOLOGY; RADIOGRAPHY; ROSEOLOVIRUS INFECTIONS;

ADULT; BLOOD; CEREBROSPINAL FLUID; DEMYELINATING DISEASES; FEMALE; FINLAND; HEAD; HERPESVIRUS 6, HUMAN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OLIGOCLONAL BANDS; ROSEOLOVIRUS INFECTIONS;

EID: 84924051931     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.07.006     Document Type: Article

References (31)

1. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
2. Akhyani N., Berti R., Brennan M.B., Soldan S.S., Eaton J.M., McFarland H.F., et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000, 182:1321-1325.
3. De Bolle L., Van Loon J., De Clercq E., Naesens L. Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 2005, 75:76-85.
4. Ablashi D.V., Devin C.L., Yoshikawa T., Lautenschlager I., Luppi M., Kuhl U., et al. Review part 3: human herpesvirus-6 in multiple non-neurological diseases. J Med Virol 2010, 82:1903-1910.
5. Razonable R.R., Lautenschlager I. Impact of human herpes virus 6 in liver transplantation. World J Hepatol 2010, 2:345-353.
6. Mori Y., Yamanishi K. HHV-6A, 6B, and 7: pathogenesis, host response, and clinical disease. Human herpesviruses: biology, therapy, and immunoprophylaxis 2007, Cambridge University Press, Cambridge. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley (Eds.).
7. Pellett P.E., Ablashi D.V., Ambros P.F., Agut H., Caserta M.T., Descamps V., et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012, 22:144-155.
8. Yao K., Crawford J.R., Komaroff A.L., Ablashi D.V., Jacobson S. Review part 2: human herpesvirus-6 in central nervous system diseases. J Med Virol 2010, 82:1669-1678.
9. Obermeier B., Mentele R., Malotka J., Kellermann J., Kumpfel T., Wekerle H., et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008, 14:688-693.
10. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
11. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846.
12. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302.
13. Andersson M., Alvarez-Cermeno J., Bernardi G., Cogato I., Fredman P., Frederiksen J., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994, 57:897-902.
14. Jesse S., Brettschneider J., Sussmuth S.D., Landwehrmeyer B.G., von Arnim C.A., Ludolph A.C., et al. Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol 2011, 258:1034-1041.
15. Pietilainen-Nicklen J., Virtanen O., Kolehmainen P., Uotila L., Salonen O., Lappalainen M., et al. ADEM and virus infection. J Clin Virol 2012, 53:2-5.
16. Sinclair A.J., Wienholt L., Tantsis E., Brilot F., Dale R.C. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology. Dev Med Child Neurol 2013, 55:71-75.
17. Leen W.G., Weemaes C.M., Verbeek M.M., Willemsen M.A., Rotteveel J.J. Chronic herpes simplex virus encephalitis in childhood. Pediatr Neurol 2006, 35:57-61.
18. Mehta P.D., Patrick B.A., Thormar H. Identification of virus-specific oligoclonal bands in subacute sclerosing panencephalitis by immunofixation after isoelectric focusing and peroxidase staining. J Clin Microbiol 1982, 16:985-987.
19. Morris P., Davies N.W., Keir G. A screening assay to detect antigen-specific antibodies within cerebrospinal fluid. J Immunol Methods 2006, 311:81-86.
20. Virtanen J.O., Pietilainen-Nicklen J., Uotila L., Farkkila M., Vaheri A., Koskiniemi M. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. J Neuroimmunol 2011, 237:93-97.
21. Virtanen J.O., Herrgard E., Valmari P., Ahlqvist J., Fogdell-Hahn A., Vaheri A., et al. Confirmed primary HHV-6 infection in children with suspected encephalitis. Neuropediatrics 2007, 38:292-297.
22. Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120(Pt 11):2059-2069.
23. Tejada-Simon M.V., Zang Y.C.Q., Hong J., Rivera V.M., Zhang J.Z. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003, 53:189-197.
24. Burgoon M.P., Hammack B.N., Owens G.P., Maybach A.L., Eikelenboom M.J., Gilden D.H. Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 2003, 54:459-463.
25. Disanto G., Morahan J.M., Barnett M.H., Giovannoni G., Ramagopalan S.V. The evidence for a role of B cells in multiple sclerosis. Neurology 2012, 78:823-832.
26. von Büdingen H.C., Harrer M.D., Kuenzle S., Meier M., Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur J Immunol 2008, 38:2014-2023.
27. Banwell B., Ghezzi A., Bar-Or A., Mikaeloff Y., Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007, 6:887-902.
28. Pohl D., Rostasy K., Reiber H., Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology 2004, 63:1966-1967.
29. Sindern E., Haas J., Stark E., Wurster U. Early onset MS under the age of 16: clinical and paraclinical features. Acta Neurol Scand 1992, 86:280-284.
30. Flamand L., Komaroff A.L., Arbuckle J.H., Medveczky P.G., Ablashi D.V. Review part 1: human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 2010, 82:1560-1568.
31. Hirabayashi K., Nakazawa Y., Katsuyama Y., Yanagisawa T., Saito S., Yoshikawa K., et al. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid. Infection 2013, 41:219-223.